OverviewSuggest Edit

    13therapeutics is a research and drug development company identifying and characterizing anti-inflammatory peptide therapeutics. It develops a platform for discovering peptides derived from naturally occurring pathogens (bacteria, viruses, fungi), which modulate the human immune response. The company offers products that have application for the treatment of a range of inflammatory diseases.

    Latest Updates

    Employees (est.) (Oct 2021)1
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    13therapeutics Financials and Metrics

    Summary Metrics

    Founding Date


    13therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    13therapeutics Online and Social Media Presence

    Embed Graph

    13therapeutics Frequently Asked Questions

    • When was 13therapeutics founded?

      13therapeutics was founded in 2008.

    • How many employees does 13therapeutics have?

      13therapeutics has 1 employees.

    • Who are 13therapeutics competitors?

      Competitors of 13therapeutics include SAVAL Pharmaceuticals, Chemo and Noven Pharmaceuticals.